Table 1 ASR per million (European population) and number of cancers among children (0–14 years) and adolescents and young adults (15–24 years)

From: Cancer incidence in English children, adolescents and young people: past trends and projections to 2030

  Males Females
  ASR Number of cases ASR Number of cases
   % change 2009–2029   % change 2009–2029   % change 2009–2029   % change 2009–2029
  1989 2009 2029 Tot Ann 1989 2009 2029 Tot Ann 1989 2009 2029 Tot Ann 1989 2009 2029 Tot Ann
Children (age: 0–14)
Leukaemias 7.6 7.5 8.1 8% 0.3% 226 231 278 20.0% 0.7% 6.1 6.4 7.2 13% 0.4% 175 188 236 25% 0.8%
HL 0.1 0.1 0.1 10% 0.3% 26 38 48 26.1% 0.9% 0.1 0.1 0.1 67% 1.9% 15 19 36 92% 2.4%
NHL 0.2 0.2 0.2 12% 0.4% 58 60 77 28.6% 0.9% 0.1 0.1 0.1 19% 0.7% 26 23 31 35% 1.1%
CNS 5.3 5.7 6.5 13% 0.4% 152 171 219 28.0% 0.9% 4.4 4.9 6.0 21% 0.7% 121 141 193 36% 1.2%
Neuroblastomas 1.5 1.2 1.4 17% 0.6% 48 39 49 26.9% 0.9% 1.4 1.1 1.4 27% 0.9% 42 35 47 36% 1.1%
Retinoblastomas 0.5 0.8 0.6 −22% −0.9% 15 26 22 −17.0% −0.7% 0.5 0.6 0.7 22% 0.7% 14 18 23 29% 0.9%
Renal 1.1 1.1 1.2 14% 0.5% 34 34 42 25.4% 0.8% 1.2 1.2 1.5 21% 0.7% 35 38 50 31% 1.0%
Hepatic 0.2 0.2 0.3 51% 1.5% 5 7 12 63.6% 1.8% 0.1 0.1 0.2 53% 1.6% 4 5 8 62% 1.8%
Bone 1.3 1.2 1.0 −15% −0.6% 34 35 35 −1.8% −0.1% 1.0 1.1 1.0 −12% −0.5% 26 30 31 2% 0.1%
Soft tissue 1.5 1.7 1.9 11% 0.4% 43 53 66 25.1% 0.8% 1.1 1.4 1.5 10% 0.4% 32 40 49 22% 0.7%
Germ cells 0.5 0.7 0.8 12% 0.4% 16 21 26 24.8% 0.8% 0.7 0.8 1.1 28% 0.9% 19 24 35 43% 1.3%
All cancers 23.5 24.5 26.3 8% 0.3% 690 744 899 20.8% 0.7% 19.4 20.1 23.5 17% 0.6% 546 584 763 31% 1.0%
Adolescents and young adults (age: 15–24)
Leukaemias 3.0 3.2 3.1 −2% −0.1% 92.3 95.3 101.5 6% 0.3% 1.8 2.1 2.1 −2% −0.1% 52.3 62.0 64.0 3% 0.2%
HL 4.7 4.7 4.9 5% 0.2% 145.0 141.3 160.0 13% 0.6% 4.4 4.5 5.8 29% 1.3% 134.0 131.7 177.5 35% 1.5%
NHL 2.5 2.4 2.8 14% 0.7% 78.3 73.3 90.5 23% 1.1% 1.2 1.1 1.8 57% 2.3% 35.7 33.3 54.8 64% 2.5%
CNS 3.4 3.6 4.0 11% 0.5% 105.0 109.7 131.1 20% 0.9% 2.8 3.0 3.2 5% 0.2% 84.0 89.3 97.9 10% 0.5%
Bone 1.5 1.7 1.9 10% 0.5% 45.3 51.7 61.7 19% 0.9% 0.9 0.9 1.2 24% 1.1% 25.7 27.7 36.3 31% 1.4%
Soft tissue 1.4 1.4 1.5 4% 0.2% 44.0 43.3 49.0 13% 0.6% 1.4 1.3 1.4 13% 0.6% 41.3 37.7 44.5 18% 0.8%
Germ cells 5.9 7.7 7.8 1% 0.1% 184.7 230.3 252.0 9% 0.4% 0.7 1.0 1.1 3% 0.2% 20.0 30.3 32.8 8% 0.4%
Melanomas 2.3 4.0 5.0 25% 1.1% 73.3 120.0 162.5 35% 1.5% 4.3 6.2 8.9 43% 1.8% 131.7 181.0 269.3 49% 2.0%
Carcinomas 2.2 3.2 4.9 52% 2.1% 68.0 97.0 159.1 64% 2.5% 6.1 8.5 13.7 61% 2.4% 187.3 249.7 415.6 66% 2.6%
All cancers 28.7 33.6 36.6 9% 0.4% 892.0 1,010.0 1,189.4 18% 0.8% 25.1 30.3 34.4 13% 0.6% 757.3 891.3 1,054.3 18% 0.8%
  1. Abbreviations: Ann=Annual; ASR=age-standardised rate; CNS=central nervous system; HL=Hodgkin’s lymphoma; NHL=non-Hodgkin’s lymphoma; Tot=total.